LitAlert ~~ GeneLit.com

    • A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial.
    • Gonzalez Martin A, Sanchez Lorenzo L, Colombo N, dePont Christensen R, Heitz F, Meirovitz M, Selle F, van Gorp T, Alvarez N, Sanchez J, Marqués C.
    • Int J Gynecol Cancer. 2020 Dec 14:ijgc-3-001633. doi: 10.1136/ijgc-2020-001633. Epub ahead of print.
    • Epidemiological and ES cell-based Functional Evaluation of BRCA2 Variants Identified in Families with Breast Cancer.
    • Sullivan T, Thirthagiri E, Chong CE, Stauffer S, Reid S, Southon E, Hassan T, Ravichandran A, Wijaya E, Lim J, Taib NAM, Fadzli F, Yip CH, Hartman M, Li J, van Dam RM; SGBCC Investigators; MYBRCA Investigators, North SL, Das R, Easton DF, Biswas K, Teo SH, Sharan SK.
    • Hum Mutat. 2020 Dec 13. doi: 10.1002/humu.24154. Epub ahead of print.
    • BRCA testing delay during the COVID-19 pandemic: How to act?
    • Minucci A, Scambia G, De Bonis M, De Paolis E, Santonocito C, Fagotti A, Capoluongo E, Concolino P, Urbani A.
    • Mol Biol Rep. 2020 Dec 12. doi: 10.1007/s11033-020-06060-8. Epub ahead of print.
    • Sichere Schwangerschaft nach Brustkrebstherapie von BRCA-Mutations-Trägerinnen? [Safe pregnancy after breast cancer treatment in patients carrying BRCA mutations?].
    • Souchon R.
    • Strahlenther Onkol. 2020 Dec 11. German. doi: 10.1007/s00066-020-01726-5. Epub ahead of print.
    • Commentary, [Article in German]
    • Population-based Screening for Hereditary Colorectal Cancer Variants in Japan.
    • Fujita M, Liu X, Iwasaki Y, Terao C, Mizukami K, Kawakami E, Takata S, Inai C, Aoi T, Mizukoshi M, Maejima K, Hirata M, Murakami Y, Kamatani Y, Kubo M, Akagi K, Matsuda K, Nakagawa H, Momozawa Y.
    • Clin Gastroenterol Hepatol. 2020 Dec 10:S1542-3565(20)31664-5. doi: 10.1016/j.cgh.2020.12.007. Epub ahead of print.
    • The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses.
    • Zhou P, Wu X, Chen H, Hu Y, Zhang H, Wu L, Yang Y, Mao B, Wang H.
    • Aging (Albany NY). 2020 Dec 9;12. doi: 10.18632/aging.202267. Epub ahead of print.
    • Long-Term Evaluation of Women Referred to a Breast Cancer Family History Clinic (Manchester UK 1987-2020).
    • Howell A, Gandhi A, Howell S, Wilson M, Maxwell A, Astley S, Harvie M, Pegington M, Barr L, Baildam A, Harkness E, Hopwood P, Wisely J, Wilding A, Greenhalgh R, Affen J, Maurice A, Cole S, Wiseman J, Lalloo F, French DP, Evans DG.
    • Cancers (Basel). 2020 Dec 9;12(12):E3697. doi: 10.3390/cancers12123697.
    • Current and future landscape of poly (ADP-ribose) polymerase inhibition resistance.
    • Hinchcliff E, Chelariu-Raicu A, Westin SN.
    • Curr Opin Obstet Gynecol. 2020 Dec 9. doi: 10.1097/GCO.0000000000000678. Epub ahead of print.
    • Review
    • Outcomes of endoscopic ultrasound as a one-off pancreatic cancer screening tool for 122 high- and moderate-risk patients.
    • Efthymiou M, Chandran S, Zorron Cheng Tao Pu L, Collins A, Rajadurai A, Nikfarjam M, Vaughan R.
    • JGH Open. 2020 Oct 17;4(6):1217-1223. doi: 10.1002/jgh3.12432. eCollection 2020 Dec.
    • Multiple cancer susceptible genes sequencing in BRCA-negative breast cancer with high hereditary risk.
    • Lang GT, Shi JX, Huang L, Cao AY, Zhang CH, Song CG, Zhuang ZG, Hu X, Huang W, Shao ZM.
    • Ann Transl Med. 2020 Nov;8(21):1417. doi: 10.21037/atm-20-2999.